Androgen Deprivation Therapy for Prostate Cancer and Alzheimer’s Risk
This article represents the opinions, thoughts, and experiences of the author; none of this content has been paid for by any advertiser. The AlzheimersDisease.net team does not recommend or endorse any products or treatments discussed herein. Learn more about how we maintain editorial integrity here.
- Nead KT, Gaskin G, Chester C, et al. Androgen deprivation therapy and future Alzheimer’s disease risk. J Clin Onc. 2016; 34(6): 566-571. Doi: 10.1200/JCO.2015.63.6266 Accessed October 7, 2019.
- Jayadevappa R, Chhatre S, Malkowicz, et al. Association between androgen deprivation therapy use and diagnosis of dementia in men with prostate cancer. JAMA Netw Open. 2019; 2(7). Doi: 10.1001/jamanetworkopen.2019.6562. Accessed October 7, 2019.
- Hormone Therapy for Prostate Cancer May Raise Risk of Alzheimer’s, Dementia. Penn Medicine. https://www.pennmedicine.org/news/news-releases/2019/july/hormone-therapy-for-prostate-cancer-may-raise-risk-of-alzheimers-dementia Published July 5, 2019. Accessed October 7, 2019.